R. Guezguez et al. / Tetrahedron Letters 47 (2006) 4807–4811
4811
for example, Refs. 5a,c). Microwave experiments were
carried out in a non-modified domestic oven (BlueSky 900
W). After a careful determination of the higher density
electric spot using an aqueous solution of cobalt chlo-
ride,17 reactions were performed in this point at the
maximum continuous power output of 900 W. To a
solution of azido-sugar 2 (1 mmol) in methylene chloride
or toluene (10 mL) was added: alkyne (1.05–1.5 equiv),
CuI (2 equiv), DIEA (5 equiv) and 1 g of silica gel. The
mixture was stirred for 5 min and the solvent was
evaporated at room temperature. The resulting yellow
powder was placed into a microwave oven and irradiated
for the desired amount of time (the final temperature was
evaluated at the end of the irradiation by digital thermo-
metric probe). The mixture was eluted twice with ethyl
acetate and the solvent evaporated under reduced pressure
to give a crude product with, in general, good purity. The
crude product could be subjected to a simple filtration on
silica gel (cyclohexane/ethyl acetate: 80/20).
H-Tol). 13C NMR (CDCl3): d 14.2, 21.8, 21.9, 22.7, 25. 8,
29.1, 29.3, 31.7, 38.5, 64.1, 75.0, 83.6, 88.9, 119.1,
125.8,129.4,129.8, 129.9,144.3, 144.6, 149.2,166.3. MS
(ES+): m/z = 528 (M+Na)+. Compound 3ca: 1H NMR
(200 MHz, CDCl3): d 0.79 (t, 3H, J = 6.7 Hz, CH3), 1.20–
1.40 (m, 10H, (CH2)5), 1.61 (m, 2H, CH2), 2.32 (s, 3H,
CH3), 2.35 (s, 3H, CH3), 2.63 (t, 2H, J = 7.8 Hz, CH2),
2.8–3.1(m, 2H, H-20), 4.55 (m, 2H, H-50), 4.70 (m, 1H, H-
40), 5.61 (td, 1H, J = 6.5 and 2.0 Hz, H-30); 6.46 (dd, 1H,
J = 5.5 and 1.5 Hz, H-10), 7.12 (d, 2H, J = 8.0 Hz, H-Tol),
7.20 (d, 2H, J = 8.0 Hz, H-Tol), 7.52 (s, 1H, H-5), 7.56 (d,
2H, J = 8.1 Hz, H-Tol), 7.87 (d, 2H, J = 8.1 Hz, H-Tol).
13C NMR (CDCl3): d 14.2 , 21.8, 22.8, 25.9, 29.3, 29.5,
29.6, 32.0, 38.8, 64.1, 74.8, 84.8, 89.9, 126.4, 126.8, 129.3,
129.4, 129.8, 144.4, 144.5, 166.1, 166.3. MS (ES+): m/
z = 534 (M+H)+, 556 (M+Na)+.
1
Compound 3cb: H NMR (200 MHz, CDCl3): d 0.80 (t,
3H, J = 6.7 Hz, CH3), 1.2–1.4 (m, 10H, (CH2)5), 1.6 (m,
2H, CH2), 2.41 (2s, 6H, 2Me), 2.62 (t, 2H, J = 7.8 Hz,
CH2), 2.8–3.1(m, 2H, H-20), 4.5 (m, 2H, H-50), 4.6 (m, 1H,
H-40), 5.7 (m, 1H, H-30), 6.44 (t, 1H, J = 6.4 Hz,H-10),
7.16 (d, 2H,J = 8.0 Hz, H-Tol), 7.20 (d, 2H, J = 8.0 Hz,
H-Tol), 7.37 (s, 1H, H-5), 7.80 (d, 2H, J = 8.2 Hz, H-Tol),
7.87 (d, 2H, J = 8.2 Hz, H-Tol). 13C NMR (CDCl3): d
14.0, 21.8, 21.9, 22.8, 25.8, 29.3, 29.4, 32.0, 38.5, 43.4, 51.9,
64.1, 75.0, 83.6, 88.9, 126.5, 126.8, 129.4, 129.8, 129.9,
144.3, 144.6,166.0, 166.3. MS (ES+): m/z = 556 (M+Na)+.
16. Selected spectral data:
Selected spectral data: Compound 3aa: 1H NMR
(200 MHz, CDCl3): d 2.27 (s, 3H, CH3), 2.36 (s, 3H,
CH3), 2.80–3.20 (m, 2H, H-20), 4.56 (m, 2H, H-50), 4.77
(m, 1H, H-40), 5.61 (td, 1H, J = 6.3 and 1.9 Hz, H-30), 6.51
(dd, 1H, J = 6.4 and 1.5 Hz, H-10), 7.07 (d, 2H,
J = 7.9 Hz, H-Tol), 7.20 (d, 2H, J = 7.9 Hz, H-Tol), 7.31
(m, 3H, H-Ph), 7.59 (d, 2H, J = 8.2 Hz, H-Tol), 7.70 (dd,
2H, J = 7.9 and 1.4 Hz, H-Ph), 7.75 (d, 2H, J = 8.2 Hz, H-
Tol), 8.05 (s, 1H, H-5). 13C NMR (CDCl3): d 21.7, 21.8,
38.9, 64.1, 74.7, 85.1, 90.2, 118.0, 125.8, 126.2, 126.8,
128.3, 128.8, 128.9, 129.3, 129.4, 129.7, 129.9, 129.9, 130.6,
144.4, 144.5, 147.9, 165.9, 166.2. MS (ES+): m/z = 520
(M+Na)+.
Compound 4aa: 1H NMR (200 MHz, CD3OD) d 2.52–
2.60 (m, 1H, H-20), 2.87–2.93 (m, 1H, H-20), 3.62 (dd, 1H,
J = 12.0 and 5.0 Hz, H-50), 3.74 (dd, 1H, J = 12.0 and
4.0 Hz, H-50), 4.31 (q, 1H, J = 4.0 Hz, H-40), 4.49 (m, 1H,
H-30); 6.50 (dd, 1H, J = 7.6 and 2.3 Hz, H-10), 7.37 (t, 1H,
J = 7.4 Hz, H-Ph), 7.46 (t, 2H, J = 7.4 Hz, H-Ph), 7.84 (m,
2H, H-Ph), 8.62 (s, 1H, H-5). 13C NMR (CD3OD): d 41.6
(C-20), 62.8 (C-50), 72.1 (C-30), 90.2 (C-40), 90.9 (C-10),
120.4 (C-5), 126.4 (C-Ph), 129.1 (C-Ph), 129.6 (C-Ph),
131.0 (C-Ph), 148.9 (C-4). MS (ES+): m/z = 284
(M+Na)+.
1
Compound 3ba: H NMR (200 MHz, CDCl3): d 0.82 (t,
3H, J = 6.4 Hz, CH3), 1.20–1.60 (m, 8H, (CH2)4), 2.32 (s,
3H, CH3), 2.35 (s, 3H, CH3), 2.63 (t, 2H, J = 7.9 Hz,
CH2), 2.80–3.20 (m, 2H, H-20), 4.65 (m, 2H, H-50), 4.70
(m, 1H, H-40), 5.55 (td, 1H, J = 4.5 and 2.0 Hz, H-30), 6.41
(dd, 1H, J = 6.3 and 1.5 Hz, H-10), 7.12 (d, 2H,
J = 8.0 Hz, H-Tol), 7.19 (d, 2H, J = 8.0 Hz, H-Tol), 7.52
(br s, 1H, H-5), 7.61 (d, 2H, J = 8.2 Hz, H-Tol), 7.87 (d,
2H, J = 8.2 Hz, H-Tol). 13C NMR (CDCl3): d 14.2, 21.8,
22.7, 25.9, 29.1, 29.6, 31.7, 38.8, 64.1, 74.8, 84.8, 89.9,
118.8, 126.4, 126.9, 129.3, 129.4, 129.8, 144.4, 144.5, 148.8,
166.1, 166.3. MS (ES+): m/z = 528 (M+Na)+.
Compound 4ab: 1H NMR (200 MHz, CD3OD) d 2.31–
2.47 (m, 1H, H-20), 2.69–2.75 (m, 1H, H-20), 3.56 (dd, 1H,
J = 11.9 and 5.0 Hz, H-50), 3.66 (dd, 1H, J = 12.0 and
4.1 Hz, H-50), 3.95 (q, 1H, J = 4.1 Hz, H-40), 4.45 (m, 1H,
H-30); 6.35 (dd, 1H, J = 5.7 and 5.6 Hz, H-10), 7.24 (tt,
1H, J = 7.5 and 1.2 Hz, H-Ph), 7.33 (tt, 2H, J = 7.9 and
1.2 Hz, H-Ph), 7.72 (m, 2H, H-Ph), 8.41 (s, 1H, H-5). 13C
NMR (CD3OD): d 41.7 (C-20), 63.2 (C-50), 72.2 (C-30),
89.7 (C-40), 90.3 (C-10), 120.8 (C-5), 126.7 (C-Ph), 129.4
(C-Ph), 129.9 (C-Ph), 131.6 (C-Ph), 148.9 (C-4). MS
(ES+): m/z = 262 (M+H)+, 284 (M+Na)+.
1
Compound 3bb: H NMR (200 MHz, CDCl3): d 0.80 (t,
3H, J = 6.8 Hz, CH3), 1.20–1.60 (m, 8H, (CH2)4), 2.34 (s,
3H, CH3), 2.36 (s, 3H, CH3), 2.55 (t, 2H, J = 8.0 Hz,
CH2), 2.70 (m, 1H, H-20), 2.70 (m, 1H, H-20), 3.01 (m, 1H,
H-20), 4.40–4.60 (m, 3H, H-50 and H-30), 5.68 (m, 1H, H-
30), 6.41 (t, 1H, J = 6.4 Hz, H-10), 7.16 (d, 2H, J = 8.0 Hz,
H-Tol), 7.20 (d, 2H, J = 8.0 Hz, H-Tol), 7.37 (s, 1H, H-5),
7.61 (d, 2H, J = 8.2 Hz, H-Tol), 7.87 (d, 2H, J = 8.2 Hz,
17. Villemin, D.; Thibault-Starzyk, F. J. Chem. Educ. 1991,
346.